HUBweek event: A Quantum Leap in Diabetes Treatment

Date: 

Monday, September 26, 2016, 8:30am to 10:00am

Location: 

Harvard University, Geological Museum Lecture Hall 100, 24 Oxford Street, Cambridge, MA

A part of the HUBweek series of events.

Hear from leading scientists, clinicians, and executives at HSCI and partner institutions who are working toward bringing stem cell-derived therapies to diabetic patients through the Boston Autologous Islet Replacement Therapy (BAIRT) Program.

Moderator:  Carey Goldberg, WBUR

Doug A. Melton, PhD
Xander University Professor and Thomas Dudley Cabot Professor in the Natural Sciences, Harvard University
Co-Director, Harvard Stem Cell Institute
Scientific Founder, Semma Therapeutics

Sayeed Malek, MD
Clinical Director, Division of Transplant Surgery, Brigham & Women’s Hospital

Peter S. Amenta, MD, PhD
President and CEO, Joslin Diabetes Center

Robert Millman, JD
CEO, Semma Therapeutics

Gordon C. Weir, MD
Co-Head, Section on Islet Cell & Regenerative Biology
Diabetes Research and Wellness Foundation Chair, Joslin Diabetes Center
Professor of Medicine, Harvard Medical School

Program is offered free of charge to the general public, but registration is required at: 
https://www.eventbrite.com/e/horizons-in-regenerative-medicine-a-quantum-leap-in-diabetes-treatment-tickets-26574743774#tickets